New potential instrument to fight hepatocellular cancer by restoring p53.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The Increased Level of Serum p53 in Hepatitis B-Associated Liver Cirrhosis.Iranian journal of medical sciences · 2014
   Article
2. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.Journal of cellular and molecular medicine · 2013
   Review
3. Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy.Hepatitis monthly · 2012
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as